UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea’s annual healthcare conference to go online only
The Korea Biotechnology Industry Organization (KBIO) said the upcoming annu...
by Kim Chan-hyuk
|
2020-09-02 11:05
라인
T&R Biofab gains sales rights of pluripotent stem cell-derived cardiomyocyte
T&R Biofab has signed a licensing agreement with iPS Academia Japan to secu...
by Shim Hyun-tai
|
2020-09-01 14:13
라인
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clini...
by Shim Hyun-tai
|
2020-08-26 17:17
라인
Drugmakers in active open innovation with startups
The local pharmaceutical industry is increasingly seeking “open innovation,...
by Kim Chan-hyuk
|
2020-08-25 11:51
라인
Samsung Bioepis wins European nod for Avastin biosimilar
Samsung Bioepis said that it has obtained a sales approval for Aybintio, a ...
by Lee Han-soo
|
2020-08-21 11:32
라인
Resurge of Covid-19 cases throw cold water on biotech events
The local pharmaceutical and biotech industries are on high alert as Covid-...
by Kim Chan-hyuk
|
2020-08-18 15:37
라인
Celltrion to start P1 trial of Prolia biosimilar
Celltrion said that it would start phase 1 clinical trial of CT-P41, a Prol...
by Lee Han-soo
|
2020-08-14 15:32
라인
Celltrion Healthcare posts record-breaking Q2 profit
Celltrion Healthcare said Thursday that it recorded sales of 420.3 billion ...
by Lee Han-soo
|
2020-08-13 16:34
라인
Organoid developed as research model for gut microbiome
Korea Research Institute of Bioscience and Biotechnology has developed a re...
by Shim Hyun-tai
|
2020-08-11 17:48
라인
Samsung Biologics to invest ₩1.7 trillion to build world’s largest plant
Samsung Biologics said Tuesday that it would invest 1.7 trillion won ($1.4 ...
by Lee Han-soo
|
2020-08-11 15:11
라인
Celltrion, Incheon to create global bio innovation cluster
Celltrion said Wednesday that it has signed an agreement with Incheon Metro...
by Shim Hyun-tai
|
2020-08-05 18:03
라인
Samsung Biologics unveils proprietary cell line tech -- S-CHOice
Samsung Biologics said Wednesday that it has launched S-CHOice, its proprie...
by Lee Han-soo
|
2020-08-05 15:23
라인
Biotech firms seek IPO amid bubble concerns
Local pharmaceutical and biotech companies are going public in August, foll...
by Kim Chan-hyuk
|
2020-08-05 15:23
라인
Celltrion to start P1 trial of Covid-19 treatment in UK
Celltrion said that the U.K.’s Medicines and Healthcare products Regulatory...
by Lee Han-soo
|
2020-07-30 16:17
라인
Samsung Bioepis' 1H biosimilar sales in EU top $390 million
Samsung Bioepis' biosimilar sales in European Union surpassed $390 mill...
by Lee Han-soo
|
2020-07-23 17:57
라인
Celltrion’s Covid-19 diagnostic kit gets CE certification
Celltrion said that its Covid-19 antigen diagnostic kit has won EU’s Confor...
by Lee Han-soo
|
2020-07-17 15:39
라인
Chunlab, Boryung to launch ‘Gut-scanning’ microbiome checkup service
Bioinformatics company Chunlab and Boryung Biopharma have agreed to launch ...
by Shim Hyun-tai
|
2020-07-13 15:47
라인
US-based Psomagen stocks shot up on 1st day of Kosdaq listing
The shares prices of Psomagen, a U.S.-based company specializing in genome ...
by Kim Chan-hyuk
|
2020-07-13 14:56
라인
Will Biogen win FDA nod for Alzheimer’s drug aducanumab?
Biogen has filed for U.S. approval for its investigational Alzheimer’s dise...
by Kim Yun-mi
|
2020-07-09 16:06
라인
Biotech firms offer bonus shares to increase liquidity
Four listed biotech companies have announced a bonus issue in the past week...
by Kim Chan-hyuk
|
2020-07-09 14:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top